Kimia Biosciences
Kimia Biosciences Share Price Chart
Kimia Biosciences last traded at ₹34.48 (2026-10-13). Over the past month the stock moved +16.8%, three months the stock moved -5.5%, year the stock moved -8.0%. Its closing range over 52 weeks is ₹25.36 – ₹39.95, with the latest close 13.7% below the high.
Closing prices up to 2026-10-13.
About Kimia Biosciences
Incorporated in 1993, Kimia Biosciences Ltd is in the business of manufacturing and sale pharmaceutical products[1]
Business Verticals:[1] a) Active Pharmaceutical Ingredients b) Commercial KSMs, Intermediates & Reagents c) Upcoming CRAM, CDMO, CRO services
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Kimia Biosciences reported sales of ₹20.72 crore (-12.1%) and net profit of ₹0.36 crore (-40.0%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 20.72 | 2.35 | 11.34 | 0.36 | 0.08 |
| Mar 2026 | 27.20 | 2.66 | 9.78 | 0.37 | 0.08 |
| Dec 2025 | 30.10 | 6.56 | 21.79 | 5.44 | 1.15 |
| Sep 2025 | 34.00 | 2.52 | 7.41 | 1.02 | 0.22 |
| Jun 2025 | 23.58 | 2.53 | 10.73 | 0.60 | 0.13 |
| Mar 2025 | 38.24 | 8.18 | 21.39 | 1.99 | 0.42 |
| Dec 2024 | 30.10 | 5.00 | 16.61 | 4.57 | 0.97 |
| Sep 2024 | 28.18 | 3.37 | 11.96 | 1.61 | 0.34 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +16.4% | +15.1% | +26.2% | +5.3% | +20.7% | +0.0% | -28.9% | -12.1% |
| Operating profit growth | – | – | +96.6% | -31.8% | -25.2% | +31.2% | -67.5% | -7.1% |
| Net profit growth | – | – | +10.6% | -58.3% | -36.6% | +19.0% | -81.4% | -40.0% |
| EPS growth | – | – | +10.5% | -56.7% | -35.3% | +18.6% | -81.0% | -38.5% |
| OPM % | 12.0% | 16.6% | 21.4% | 10.7% | 7.4% | 21.8% | 9.8% | 11.3% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Kimia Biosciences reported sales of ₹115.00 crore (-3.4%) and net profit of ₹7.00 crore (-30.0%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 115.00 | 14.00 | 12.00 | 7.00 | 1.57 |
| Mar 2025 | 119.00 | 20.00 | 17.00 | 10.00 | 2.03 |
| Mar 2024 | 105.00 | 0.00 | 0.00 | -5.00 | -1.12 |
| Mar 2023 | 129.00 | -5.00 | -4.00 | -9.00 | -1.98 |
| Mar 2022 | 125.00 | 1.00 | 0.00 | -4.00 | -0.78 |
| Mar 2021 | 133.00 | 8.00 | 6.00 | 5.00 | 1.08 |
| Mar 2020 | 106.00 | 4.00 | 4.00 | 1.00 | 0.30 |
| Mar 2019 | 94.00 | 6.00 | 6.00 | 4.00 | 2.64 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +23.7% | +12.8% | +25.5% | -6.0% | +3.2% | -18.6% | +13.3% | -3.4% |
| Operating profit growth | +200.0% | -33.3% | +100.0% | -87.5% | -600.0% | – | – | -30.0% |
| Net profit growth | +100.0% | -75.0% | +400.0% | -180.0% | – | – | – | -30.0% |
| EPS growth | +16.8% | -88.6% | +260.0% | -172.2% | – | – | – | -22.7% |
| OPM % | 6.0% | 4.0% | 6.0% | 0.0% | -4.0% | 0.0% | 17.0% | 12.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Kimia Biosciences.
Get Free AI Stock Analysis FREE →Latest News
-
Kimia Biosciences reports Profit after tax of Rs 3.55 Mln, in the June 2026 quarter
-
Kimia Biosciences standalone net profit declines 40.00% in the June 2026 quarter - business-standard.com
-
Kimia Biosciences Ltd Forms Golden Cross, Indicating Potential Bullish Breakout
-
Golden Cross Forms in Kimia Biosciences Ltd — On a Day the Stock Fell 1.35%. What the Mixed Signals Mean
Frequently Asked Questions
What is Kimia Biosciences's current stock price?
Kimia Biosciences shares were last quoted at ₹34.48 (+1.1% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Kimia Biosciences?
Kimia Biosciences has a price-to-earnings (P/E) ratio of 20.69 and a price-to-book (P/B) ratio of 8.23. The industry P/E is 52.82.
What is the 52-week high and low of Kimia Biosciences?
The 52-week high of Kimia Biosciences is ₹43.28 and the 52-week low is ₹23.20.
What is the market cap of Kimia Biosciences?
The market capitalisation of Kimia Biosciences is about ₹148.80 crore.
How did Kimia Biosciences perform in its latest quarterly results?
In the latest quarter (Jun 2026), Kimia Biosciences reported sales of ₹20.72 crore (-12.1%) and net profit of ₹0.36 crore (-40.0%), compared with the same quarter last year.
Is Kimia Biosciences a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Kimia Biosciences has a 3-year ROE of 54.00%, 3-year profit growth of 43.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Kimia Biosciences?
Promoters hold about 74.94% of Kimia Biosciences.
Which sector does Kimia Biosciences belong to?
Kimia Biosciences belongs to the Pharmaceuticals & Drugs sector.